Pacer Advisors, Inc. Repligen Corp Transaction History

Pacer Advisors, Inc.

$39 Billion
Q2 2024

A detailed history of Pacer Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 12,862 shares of RGEN stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,862

Previous 11,054 16.36%

Holding current value

$1.87 Million

Previous $2.03 Million 20.27%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $216,960 - $330,773	1,808 Added 16.36%	12,862 $1.62 Million
Q1 2024 May 10, 2024	BUY	$170.78 - $208.42 $41,157 - $50,229	241 Added 2.23%	11,054 $2.03 Million
Q4 2023 Jan 16, 2024	BUY	$114.17 - $185.35 $491,844 - $798,487	4,308 Added 66.23%	10,813 $1.94 Million
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $861,685 - $1.1 Million	-6,209 Reduced 48.84%	6,505 $1.03 Million
Q2 2023 Jul 12, 2023	BUY	$138.42 - $180.31 $1.33 Million - $1.73 Million	9,604 Added 308.81%	12,714 $1.8 Million
Q1 2023 May 02, 2023	SELL	$154.26 - $198.1 $1.05 Million - $1.34 Million	-6,784 Reduced 68.57%	3,110 $523,000
Q4 2022 Feb 06, 2023	BUY	$162.42 - $220.56 $1.02 Million - $1.39 Million	6,307 Added 175.83%	9,894 $1.68 Million
Q3 2022 Oct 18, 2022	BUY	$160.42 - $256.21 $514,948 - $822,434	3,210 Added 851.46%	3,587 $671,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $122,954 - $164,329	-874 Reduced 69.86%	377 $61,000
Q1 2022 Apr 05, 2022	SELL	$161.19 - $257.96 $1.02 Million - $1.64 Million	-6,342 Reduced 83.52%	1,251 $235,000
Q4 2021 Feb 03, 2022	BUY	$247.59 - $304.47 $119,585 - $147,059	483 Added 6.79%	7,593 $2.01 Million
Q3 2021 Oct 15, 2021	SELL	$194.77 - $324.21 $15,581 - $25,936	-80 Reduced 1.11%	7,110 $2.06 Million
Q2 2021 Jul 21, 2021	BUY	$165.87 - $220.95 $274,846 - $366,114	1,657 Added 29.95%	7,190 $1.44 Million
Q1 2021 Apr 05, 2021	BUY	$180.37 - $226.26 $41,485 - $52,039	230 Added 4.34%	5,533 $1.08 Million
Q4 2020 Jan 20, 2021	SELL	$148.08 - $206.57 $913,061 - $1.27 Million	-6,166 Reduced 53.76%	5,303 $1.02 Million
Q3 2020 Oct 19, 2020	BUY	$122.51 - $158.27 $1.39 Million - $1.8 Million	11,355 Added 9960.53%	11,469 $1.69 Million
Q1 2020 Apr 23, 2020	SELL	$84.96 - $109.14 $1.34 Million - $1.72 Million	-15,803 Reduced 99.28%	114 $12,000
Q4 2019 Feb 10, 2020	SELL	$73.84 - $93.08 $67,711 - $85,354	-917 Reduced 5.45%	15,917 $1.47 Million
Q3 2019 Oct 10, 2019	BUY	$76.65 - $95.51 $1.29 Million - $1.61 Million	16,834 New	16,834 $1.29 Million
Q4 2018 Feb 13, 2019	SELL	$48.26 - $68.88 $101,297 - $144,579	-2,099 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $98,233 - $123,778	2,099 New	2,099 $116,000
Q1 2018 May 14, 2018	SELL	$30.92 - $37.27 $22,417 - $27,020	-725 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $23,584 - $28,217	725	725 $26,000

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

53.9M

Call Options Held

420K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.09B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Repligen Corp Transaction History